Fibroblast Growth Factor (FGF) & Receptor Dysregulation in Cancer

When Fibroblast Growth Factors (FGFs) binding with FGFRs in a FGF:FGFR:HPSG ternary complex form, dimerization of FGFRs occurs, which causes the receptors to be phosphorylated at the intracellular tyrosine kinase domain and carboxy-terminal tail. Subsequently, the phosphorylated tyrosine recruits specific molecules, which interact with SH2 (Src homology-2) or PTB (phosphotyrosine binding) domains of adaptors docking proteins or signaling enzymes, forming signaling complexes. Then, a cascade of phosphorylation events occurs at the recruited complexes and induces a number of signaling pathways, such as the RAS/MAP kinase pathway, PI3 kinase/AKT pathway, and PLCγ pathway, resulting in specific cellular responses.

Fibroblast Growth Factor & Receptor / Fibroblast Growth Factor (FGF) Signalling

Fig 6. Fibroblast Growth Factor (FGF) Signalling

Fibroblast Growth Factor (FGF) Signalling Pathway Related Studies

23000+ Products
cDNA Clones
Recombinant Cytokines
FGF Information
What is FGF
History of FGF & Receptor
Classification of FGF & Receptor
Mechanisms of FGF Action
Fibroblast Growth Factor (FGF) Receptors
FGF Signalling Pathway
FGF & Receptor Dysregulation in Cancer
FGF Inhibitor
FGF Reagents
FGF Proteins
FGF Antibodies
FGF cDNA Clones
All FGF Products
Growth Factor Family
Ephrin & Eph Receptor
EGF & Receptor
FGF & Receptor
Insulin-like Growth Factor System
Neurotrophin & Receptor
PDGF & Receptor
Receptor Tyrosine Kinase
R-Spondin Protein
VEGF & Receptor
Wnt Ligands & Receptors